Drugs & Targets FDA Updates Zytiga Label To Include Chemotherapy-Naive Metastatic CRPC Data April 30, 2015Vol.38 No.04
Three Xtandi Trials Show Positive Results In Castration-Resistant Prostate Cancer April 30, 2015Vol.38 No.04
Study Shows 73% Survival at Three Years by Combining Radiation Therapy and Chemotherapy March 31, 2015Vol.38 No.03
Drugs & Targets FDA Grants Accelerated Approval to Farydak For Patients with Multiple Myeloma March 31, 2015Vol.38 No.03
Provenge Immune Response Continued For Two Years in Phase II Study in BRPC March 31, 2015Vol.38 No.03
Phase III Trial of Imbruvica Unblinded Following Significant Increase in PFS March 31, 2015Vol.38 No.03
